| 
		U.S. jury's mixed Theranos verdict complicates Holmes' potential appeal 
		-experts
		 Send a link to a friend 
		
		 [January 05, 2022] 
		By Jody Godoy 
 (Reuters) - Theranos founder Elizabeth 
		Holmes is likely to appeal her conviction for defrauding investors in 
		the blood-testing company, but four legal experts say the fact that the 
		jury acquitted her or failed to reach a verdict on several counts could 
		work against her.
 
 Holmes on Monday was found guilty of defrauding investors in the once 
		high-flying Silicon Valley blood-testing startup, but she was acquitted 
		of deceiving patients. The guilty verdict on four of 11 counts came 
		after a months-long trial .
 
 A jury found the former Silicon Valley entrepreneur guilty of conspiring 
		to dupe investors and of defrauding three private investors. The jury 
		deadlocked on charges related to other investors, and acquitted Holmes 
		of swindling patients.
 
 Holmes' lawyers have not yet said whether she would appeal. Attorneys 
		for Holmes did not respond to a request for comment on Tuesday.
 
 Legal experts not involved in the case said that the fact jurors found 
		in Holmes' favor on some charges will weaken arguments that they were 
		confused or biased.
 
 "In a mixed verdict, it's very hard to say that the jury rushed to 
		judgment," said Carrie Cohen, a white-collar defense attorney and former 
		prosecutor in New York. "It appears that they didn't take evidence from 
		one crime and use it to say, 'Well, she lied to one investor. She must 
		have lied to the three other investors.'"
 
 
		
		 
		The experts said a likely focus of an appeal would be rulings made by 
		U.S. District Judge Edward Davila in favor of prosecutors during or 
		before the trial, such as allowing jurors to see a regulatory report 
		from 2015 saying that the conditions in Theranos' lab posed "immediate 
		jeopardy to patient health and safety."
 
		Her attorneys had challenged prosecutors' use of the report, arguing it 
		was irrelevant and would unfairly prejudice jurors against Holmes. The 
		judge found that the evidence could be used to show that Holmes was 
		aware of problems at Theranos. 
 [to top of second column]
 | 
            
			 
            
			Theranos founder Elizabeth Holmes and her family leave the federal 
			court after a U.S. jury found Holmes guilty in her fraud trial, in 
			San Jose, California, U.S. January 3, 2022. REUTERS/Brittany 
			Hosea-Small 
            
			
			
			 The report was among the evidence 
			introduced during the testimony of 29 government witnesses.
 But appeals courts are hesitant to disturb jury verdicts, and would 
			consider whether any erroneous ruling was significant enough to have 
			impacted the result, said Vanderbilt Law School professor 
			Christopher Slobogin.
 
 Another focus for a potential appeal would be the instructions the 
			jury received before deliberations, including on the meaning of 
			"reasonable doubt." The judge denied Holmes' call for further 
			instructions on that legal standard, which sets a high bar for 
			conviction in criminal cases.
 
 In the United States, criminal defendants are presumed innocent 
			unless proven guilty beyond a reasonable doubt.
 
 Cohen said that arguing the jury was confused about the standard may 
			be an "uphill battle" since it decided to acquit on some counts.
 
 But the mixed verdict may prove helpful at Holmes' sentencing, said 
			Amanda Kramer, a partner at Covington & Burling.
 
 Holmes' attorneys will likely argue that her conviction on only some 
			of the counts after a nearly four-month trial shows "she wasn't some 
			snake oil salesperson out there just trying to rip people off."
 
 "The defense will argue to the judge that that's really meaningful, 
			that she stands apart from the predatory fraudsters that are found 
			guilty across the board," Kramer said.
 
 (Reporting by Jody Godoy in New York; Editing by Noeleen Walder and 
			Matthew Lewis)
 
			[© 2022 Thomson Reuters. All rights 
				reserved.  This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content.] 
			
			 |